top of page

論文

篩選條件：

Plasma Cell-free RNA Sequencing Enables Sensitive Detection of Lung Cancer

Publications

2023年9月10日

Plasma Cell-free RNA Sequencing Enables Sensitive Detection of Lung Cancer

Read More
Plasma Cell-free RNA Sequencing Enables Sensitive Detection of Lung Cancer
Assessing the utility of liquid biopsy for determining actionable genetic mutations among indigenous Ghanaian women with metastatic Breast Cancer

Publications

2023年5月31日

Assessing the utility of liquid biopsy for determining actionable genetic mutations among indigenous Ghanaian women with metastatic Breast Cancer

Read More
Assessing the utility of liquid biopsy for determining actionable genetic mutations among indigenous Ghanaian women with metastatic Breast Cancer
Liquid biopsy in combination with PET/CT versus PET/CT alone in diagnosis of lung cancer in small nodules.

Publications

2023年5月31日

Liquid biopsy in combination with PET/CT versus PET/CT alone in diagnosis of lung cancer in small nodules.

Read More
Liquid biopsy in combination with PET/CT versus PET/CT alone in diagnosis of lung cancer in small nodules.
Longitudinal tracking of ALK-positive lung cancer from plasma using circulating-tumor RNA and circulating-tumor DNA in the BRIGHTSTAR clinical trial

Publications

2023年5月31日

Longitudinal tracking of ALK-positive lung cancer from plasma using circulating-tumor RNA and circulating-tumor DNA in the BRIGHTSTAR clinical trial

Read More
Longitudinal tracking of ALK-positive lung cancer from plasma using circulating-tumor RNA and circulating-tumor DNA in the BRIGHTSTAR clinical trial
Development and evaluation of a multi-cancer screening (MCS) test for cancers common in Asia.

Publications

2023年5月31日

Development and evaluation of a multi-cancer screening (MCS) test for cancers common in Asia.

Read More
Development and evaluation of a multi-cancer screening (MCS) test for cancers common in Asia.
Combining plasma and tissue next-generation sequencing provides optimal treatment selection for metastatic NSCLC: a comparative study.

Publications

2023年5月31日

Combining plasma and tissue next-generation sequencing provides optimal treatment selection for metastatic NSCLC: a comparative study.

Read More
Combining plasma and tissue next-generation sequencing provides optimal treatment selection for metastatic NSCLC: a comparative study.
Complete mutation concordance with amplicon-based NGS between peripheral blood and bone marrow at 0.5% VAF threshold

Publications

2023年5月1日

Complete mutation concordance with amplicon-based NGS between peripheral blood and bone marrow at 0.5% VAF threshold

Read More
Complete mutation concordance with amplicon-based NGS between peripheral blood and bone marrow at 0.5% VAF threshold
Clinical Validation of a Promising New Amplicon-Based Liquid Biopsy Platform for Detection of Guideline Recommended Biomarkers in Metastatic NSCLC

Publications

2023年3月1日

Clinical Validation of a Promising New Amplicon-Based Liquid Biopsy Platform for Detection of Guideline Recommended Biomarkers in Metastatic NSCLC

Read More
Clinical Validation of a Promising New Amplicon-Based Liquid Biopsy Platform for Detection of Guideline Recommended Biomarkers in Metastatic NSCLC
Liquid biopsy NGS test identifies actionable DNA mutations from CSF specimens of lung cancer patients

Publications

2022年11月1日

Liquid biopsy NGS test identifies actionable DNA mutations from CSF specimens of lung cancer patients

Read More
Liquid biopsy NGS test identifies actionable DNA mutations from CSF specimens of lung cancer patients

1

/

8

bottom of page